Tower Research Capital LLC (TRC) - BIOXCEL THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,318
-72.7%
4,078
-28.2%
0.00%
-100.0%
Q2 2023$37,823
+130324.1%
5,679
+271.4%
0.00%0.0%
Q1 2023$29
+163.6%
1,529
+205.2%
0.00%
Q4 2022$11
-99.9%
501
-59.9%
0.00%
Q3 2022$15,000
-57.1%
1,250
-52.4%
0.00%
-100.0%
Q2 2022$35,000
-49.3%
2,628
-20.8%
0.00%0.0%
Q1 2022$69,000
-27.4%
3,317
-29.3%
0.00%
-50.0%
Q4 2021$95,000
-33.6%
4,690
+0.1%
0.00%
-50.0%
Q3 2021$143,000
+521.7%
4,686
+475.0%
0.00%
+300.0%
Q2 2021$23,000
-68.9%
815
-52.5%
0.00%0.0%
Q1 2021$74,000
+1750.0%
1,716
+1850.0%
0.00%
Q4 2020$4,000
-94.8%
88
-95.0%
0.00%
-100.0%
Q3 2020$77,000
-75.6%
1,770
-70.3%
0.00%
-92.3%
Q2 2020$316,000
+10433.3%
5,963
+4910.9%
0.01%
Q1 2020$3,000
-66.7%
119
-90.8%
0.00%
-100.0%
Q3 2019$9,000
+125.0%
1,291
+243.4%
0.00%
Q2 2019$4,0000.0%376
-66.5%
0.00%
Q4 2018$4,000
+100.0%
1,122
+247.4%
0.00%
Q3 2018$2,000
+100.0%
323
+223.0%
0.00%
Q1 2018$1,0001000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 40,000$836,0001.01%
ACT CAPITAL MANAGEMENT, LLC 20,000$418,0000.44%
Knoll Capital Management, LLC 20,000$418,0000.26%
Artemis Investment Management LLP 1,428,228$29,855,0000.24%
Rubric Capital Management LP 268,528$5,615,0000.20%
Virtus ETF Advisers LLC 7,713$161,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 107,700$2,252,0000.05%
PDT Partners, LLC 28,031$586,0000.05%
AllSquare Wealth Management LLC 3,162$66,0000.04%
Hennion & Walsh Asset Management, Inc. 35,221$736,0000.04%
View complete list of BIOXCEL THERAPEUTICS INC shareholders